In the wake of the 2015 emissions scandal that shook the automotive industry, th...
In a groundbreaking advancement for renewable energy technology, researchers at ...
To assist in ensuring that pulse oximeters function appropriately across all ski...
Orbis Medicines has raised €90m ($94m) in Series A funding to advance the develo...
Sickle cell patient advocacy groups in the US are calling for greater education ...
GSK has gained US FDA breakthrough therapy designation for GSK'227 to treat adul...
Acelyrin plans to initiate two Phase III studies this quarter, which will enrol ...
Variant has entered a multi-year research partnership with Novo Nordisk to ident...
Candid plans to conduct first-in-human studies in 2026 as it continues its T-cel...
The transaction is expected to close in the first half of 2025, subject to the s...
The FDA has accepted for filing and priority review Sentynl Therapeutics’ CUTX-1...
The FDA has granted ODD to Tempest's amezalpat (TPST-1120), for individuals with...
Recent research published in the esteemed European Heart Journal has unearthed c...
A groundbreaking study co-led by scientists from UCLA reveals a novel therapeuti...
The mental health landscape for children and adolescents in the UK is increasing...
